Disturbance of the reciprocal-interaction between the OXTergic and DAergic systems in the CNS causes atypical social behavior in syntaxin 1A knockout mice

Behav Brain Res. 2021 Sep 10:413:113447. doi: 10.1016/j.bbr.2021.113447. Epub 2021 Jul 2.

Abstract

Several studies have shown that oxytocin (OXT) modulates social behavior. Similarly, monoamines such as dopamine (DA) play a role in regulating social behavior. Previous studies have demonstrated that the soluble N-ethylmaleimide-sensitive fusion attachment protein receptor (SNARE) protein syntaxin 1A (STX1A) regulates the secretion of OXT and monoamines, and that STX1A gene knockout (STX1A KO) mice exhibit atypical social behavior, such as deficient social recognition, due to reduced OXT release. In this study, we analyzed the neural mechanism regulating social behavior by OXT and/or DA using STX1A KO mice as a model animal. We found that OXT directly induced DA release from cultured DA neurons through OXT and V1a receptors. In STX1A KO mice, the atypical social behavior was partially improved by OXT administration, which was inhibited by D1 receptor blockade. In addition, the atypical social behavior in STX1A KO mice was partially improved by facilitation of DAergic signaling with the DA reuptake inhibitor GBR12909. Moreover, the amelioration by GBR12909 was inhibited by OXTR blockade. These results suggest that the reciprocal interaction between the DAergic and OXTergic neuronal systems in the CNS may be important in regulating social behavior.

Keywords: Dopamine; Oxytocin; Social behavior; Syntaxin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Behavioral Symptoms / drug therapy
  • Behavioral Symptoms / metabolism*
  • Cells, Cultured
  • Central Nervous System / drug effects
  • Central Nervous System / metabolism*
  • Chemotactic Factors / metabolism*
  • Disease Models, Animal
  • Dopamine / metabolism*
  • Dopamine Antagonists / pharmacology
  • Dopaminergic Neurons / metabolism*
  • Mice
  • Mice, Knockout
  • Oxytocin / metabolism*
  • Oxytocin / pharmacology
  • Piperazines / pharmacology
  • Receptors, Dopamine D1 / antagonists & inhibitors
  • Receptors, Oxytocin / antagonists & inhibitors
  • Receptors, Oxytocin / metabolism*
  • Social Behavior*
  • Syntaxin 1 / deficiency
  • Syntaxin 1 / metabolism*

Substances

  • (1-(2-(bis(4-fluorophenyl)methoxy)ethyl)-4-(3-hydroxy-3-phenylpropyl) piperazinyl decanoate)
  • Chemotactic Factors
  • Dopamine Antagonists
  • Drd1 protein, mouse
  • OXTR protein, mouse
  • Piperazines
  • Receptors, Dopamine D1
  • Receptors, Oxytocin
  • Stx1a protein, mouse
  • Syntaxin 1
  • V1ra1 protein, mouse
  • Oxytocin
  • Dopamine